Bethesda, MD – On July 1, 2014, the Federation of American Societies for Experimental Biology (FASEB) welcomed its new President, Joseph R. Haywood, PhD. Dr. Haywood is Professor of Pharmacology and Toxicology and Assistant Vice President for Regulatory Affairs at Michigan State University (MSU). In 2012, he served as FASEB Vice President for Science Policy and has also served as Chair of FASEB’s Animals in Research & Education Subcommittee and Public Affairs Committee. Dr. Haywood is an active member of two FASEB societies. He is a member of the American Physiological Society and has served on its Council, and he is a member of the American Society for Pharmacology and Experimental Therapeutics.
“FASEB is a respected voice of advocacy for biomedical research and sound positions on science policy. I am honored to have the opportunity to further these aims while bringing focus to the important challenges facing the scientific community such as the continued need for federal support for science and the impact of regulatory burden. I look forward to working with my colleagues in all the FASEB societies to join me in addressing these and other issues affecting us this year,” stated Dr. Haywood.
Dr. Haywood’s research interests are in the area of neurohumoral control of arterial pressure, especially in experimental models of hypertension. He has focused on the action of circulating hormones and diet on neurotransmitter control of the paraventricular nucleus of the hypothalamus in regulating the sympathetic nervous system. Dr. Haywood received his PhD at the University of Florida and did post-doctoral work at the Cardiovascular Center at the University of Iowa. He joined the Department of Pharmacology at the University of Texas Health Science Center at San Antonio in 1979 where he rose through the ranks to Professor. In 2002, Dr. Haywood joined the Department of Pharmacology and Toxicology at MSU as Professor and Chair, and in 2011 he became Assistant Vice President for Regulatory Affairs.
Dr. Haywood has served on editorial boards for the American Journal of Physiology, Hypertension, Physiological Genomics, and Clinical and Experimental Physiology and Pharmacology. Dr. Haywood has been an advocate for the humane care of animals in research and teaching by serving on the Council of the Association for the Assessment and Accreditation of Laboratory Animal Care International and the Board of Governors of the International Council for Laboratory Animal Science.
Additional new FASEB officers include President-Elect Parker B. Antin, PhD; Vice President for Science Policy Hudson H. Freeze, PhD; and Treasurer Mark O. Lively, PhD. In addition, Thomas O. Baldwin, PhD, was elected Vice President-Elect for Science Policy. Dr. Antin is Associate Dean for Research in the College of Agriculture and Life Sciences, and Professor of Cellular and Molecular Medicine at the University of Arizona. He has served as Chair of FASEB’s NIH Issues Subcommittee. Dr. Antin is a member of the American Association of Anatomists and the Society for Developmental Biology. Dr. Freeze is a Professor of Glycobiology and Director of the Human Genetics Program at the Sanford-Burnham Medical Research Institute in San Diego. Dr. Freeze is a member of the Society for Glycobiology and the American Society for Biochemistry and Molecular Biology. Dr. Lively is Professor Emeritus of Biochemistry at Wake Forest University School of Medicine, and previously served as FASEB President and Vice President for Science Policy. He is a member of the Association of Biomolecular Resource Facilities and the American Society for Biochemistry and Molecular Biology. Dr. Baldwin is Professor of Biochemistry at the University of California, Riverside, represents the American Society for Biochemistry and Molecular Biology on the FASEB Board of Directors, and is a member of The Protein Society.
FASEB is composed of 27 societies with more than 120,000 members, making it the largest coalition of biomedical research associations in the United States. Our mission is to advance health and welfare by promoting progress and education in biological and biomedical sciences through service to our member societies and collaborative advocacy.